Top news of the week: 29.09.2021.
Startups
‘Enthusiastic Entrepreneurs’: Pre-IPO Statements On Profitability Prove To Be Larger Than Real Life
More than one in four of the 50 largest venture-backed companies to go public since 2019 made assertions about their profitability that don’t appear to line up with their later IPO-related ...
Fierce Biotech's 2021 Fierce 15
COVID-19 was inevitably the focus of Fierce 15 last year. This year, it’s pretty much more of the same as we see how the sector has and continues to navigate the pandemic while raising ...
Toast’s Stock Pops In Boston’s Biggest Ever IPO, Minting Cofounders As Billionaires
The stock offering comes 16 months after Toast laid off half its employees.
Biotech Is on a Hiring Binge, But Lags Behind on Diversity
It’s been a roaring year for the sector. But a survey finds women and people of color are still underrepresented at the top.
Meet Private Equity’s Quiet Corporate Turnaround Artist
Advent International’s David Mussafer cuts a low profile on Wall Street, but his firm’s ability to reshape large companies has turned the firm from an also-ran into a fast-growing giant ...
What Drives Newly Minted CRISPR Unicorn Mammoth Biosciences
Mammoth Biosciences has raised $195 million to build next-generation CRISPR products in therapeutics and diagnostics that can cure and detect diseases. Mammoth has now reached unicorn ...
The 3 most powerful psychedelics VCs dish on what they look for — and avoid — when investing in new companies
Insider asked Noetic Fund, Palo Santo, and Neo Kuma about their strategies when deciding whether to invest in a company.
Ring Therapeutics
Ring Therapeutics is exploring a variety of potential areas to pursue, including vaccines, ophthalmology and cardiology. All of them have potential for the company's anellovirus gene ...